Effect of alpha7 nicotinic acetylcholine receptor agonists on attentional set-shifting impairment in rats

Cortical circuit dysfunction and cognitive deficits in schizophrenia - implications for preemptive interventions

(2012) David A. Lewis   EUROPEAN JOURNAL OF NEUROSCIENCE

Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease

(2011) Tanya L. Wallace et al.   BIOCHEMICAL PHARMACOLOGY

Delayed procedural learning in α7-nicotinic acetylcholine receptor knockout mice

(2011) J. W. Young et al.   GENES BRAIN AND BEHAVIOR

PNU-120596, a positive allosteric modulator of α7 nicotinic acetylcholine receptors, reverses a sub-chronic phencyclidine-induced cognitive deficit in the attentional set-shifting task in female rats

(2011) Samantha L McLean et al.   JOURNAL OF PSYCHOPHARMACOLOGY

An analysis of rat prefrontal cortex in mediating executive function

(2011) Raymond P. Kesner et al.   NEUROBIOLOGY OF LEARNING AND MEMORY

EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors

(2011) Jos Prickaerts et al.   NEUROPHARMACOLOGY

Glutamate and nicotinic receptor interactions in working memory: importance for the cognitive impairment of schizophrenia

(2011) O.A. Timofeeva et al.   NEUROSCIENCE

Effects of olanzapine, sertindole and clozapine on MK-801 induced visual memory deficits in mice

(2011) Oguz Mutlu et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Neurocognitive Predictors of Work Outcome in Recent-Onset Schizophrenia

(2011) K. H. Nuechterlein et al.   SCHIZOPHRENIA BULLETIN

Activation of type 5 metabotropic glutamate receptors attenuates deficits in cognitive flexibility induced by NMDA receptor blockade

(2010) Mark R. Stefani et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: Implications for therapy of cognitive dysfunction in schizophrenia

(2010) Samantha L. McLean et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

RG3487, a Novel Nicotinic  7 Receptor Partial Agonist, Improves Cognition and Sensorimotor Gating in Rodents

(2010) T. L. Wallace et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test

(2010) Jesper T Andreasen et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Serotonin and Dopamine: Unifying Affective, Activational and Decision Functions

(2010) Roshan Cools et al.   NEUROPSYCHOPHARMACOLOGY

Meta-analysis of the acute effects of nicotine and smoking on human performance

(2010) Stephen J. Heishman et al.   PSYCHOPHARMACOLOGY

Selective α7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes

(2009) Simon Sydserff et al.   BIOCHEMICAL PHARMACOLOGY

TC-5619: An alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia

(2009) T.A. Hauser et al.   BIOCHEMICAL PHARMACOLOGY

A 2-base pair deletion polymorphism in the partial duplication of the α7 nicotinic acetylcholine gene (CHRFAM7A) on chromosome 15q14 is associated with schizophrenia

(2009) Melissa L. Sinkus et al.   BRAIN RESEARCH

α7 and non-α7 nicotinic acetylcholine receptors modulate dopamine releasein vitroandin vivoin the rat prefrontal cortex

(2009) Phil D. Livingstone et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Differential Regulation of α7 Nicotinic Receptor Gene (CHRNA7) Expression in Schizophrenic Smokers

(2009) Sharon Mexal et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Association of the 5′-upstream regulatory region of the α7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia

(2009) Sarah H. Stephens et al.   SCHIZOPHRENIA RESEARCH

CATIE and CUtLASS: can we handle the truth?

(2008) Shôn Lewis et al.   BRITISH JOURNAL OF PSYCHIATRY